期刊文献+

血清ALT及HBA DNA水平与慢性乙型肝炎炎症活动度的关系 被引量:3

Relationship between the levels of ACT. HNA and DNA of serum and inflammatory activity of chronic hepatitis B
下载PDF
导出
摘要 目的:了解慢性乙型病毒性肝炎炎症活动度与血清丙氨酸转氨酶(ALT)及乙型肝炎病毒(HBV)定量的关系。方法:对97例慢性乙型肝炎患者肝穿组织进行炎症活动度分级,并定量检测血清中的ALT及HBV DNA。结果:患者血清ALT与炎症活动度不一致率为 24.74%(24/97)。中度及重度慢性肝炎组不一致率达 43.33%(13/30),高于轻度慢性肝炎组的不一致率16.42%(P>0.005)。各级慢性乙型肝炎中HBV定量的差异无显著性(P>0.05)。结论ALT不能完全反应慢性乙型肝炎的炎症活动度,而HBV DNA定量检测亦无助于了解慢性乙型肝炎的炎症活动度。
出处 《现代医药卫生》 2001年第5期333-334,共2页 Journal of Modern Medicine & Health
  • 相关文献

参考文献4

  • 1回允中主译.阿克曼外科病理学[M].沈阳:辽宁教育出版社,1999.1331.
  • 2周小辉 周元平 姚春兰.慢性乙型肝炎患者血清HBV DNA含量与肝细胞损伤程度的关系[J].中华肝脏病杂志,1999,7(3):167-167.
  • 3Zavaglia C, Mondazzi L, Maggi G, et al. Are alanine amino transferase, hepatitis B virus DNA or IgM antibody to hepatitis B core antigen serum levels predictors of histological grading in chronis hepatitis B. Liver, 1997; 17(2) :83
  • 4Lindh M,Horal P,Dhillon AP,et al. Hepatitis B virus DNA levels, precore mutations,genotypes and histological activity in chronec hepatitis B.J Viral Hepat, 2000;7(4)258

共引文献25

同被引文献17

  • 1秦刚,施光峰,宋艳艳,陈明泉.甘草酸二铵治疗慢性乙型肝炎3201例荟萃分析[J].中华传染病杂志,2005,23(5):333-337. 被引量:55
  • 2唐跃华,谢健敏,梁玉全,刘建辉.慢性乙型肝炎患者血清HBeAg、HBVDNA与肝组织炎症关系的探讨[J].中华传染病杂志,2005,23(5):338-341. 被引量:27
  • 3许建新,齐为民,刘茂贤,吴晟.肝病776例胆碱酯酶活性测定结果分析[J].陕西医学杂志,1997,26(2):108-109. 被引量:28
  • 4Manesis EK, Papatheodoridis GV, Hadziyannnis SJ. Serum HBV DNA levels in inactive hepatitis B virus carriers. Gastroenterology, 2002,122: 2092-2093.
  • 5方益荣 郝加虎 叶冬青.HBV前C区突变研究进展[J].国外医学:流行病学病,1999,6:81-84.
  • 6Maini MK,Boni C,Lee CK,et al.The role of virus-specific CD8+ cells in liver damage and viral control during persistent hepatitis B virus infection.J Exp Med,2000,191:1269-1280.
  • 7Guidotti LG,Rochford R,Chung J,et al.Viral clearance without destruction of infected cells during acute HBV infection.Science,1999,284:825-829.
  • 8Boni C,Penna A,Ogg GS,et al.Lamivudine treatment can o vercomecytotoxic T-cell hyporesponsiveness in chronic hepatitis B:new perspectives for immune therapy.Hepatology,2001,33:963-971.
  • 9Tasi SL,Sheen IS,Chien RN,et al.Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C:tetramer assay and therapeutic implication.J Biomed Sci,2003,10:120-135.
  • 10DesmetVJ, GerberM, HoofnagleJH, et al. Classification of chronic hepatitis: diagnosis, grading and staging. [ J ]. Hepatology, 1994,19 : 1513.

引证文献3

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部